The status of antithymocyte globulin therapy for adult patients in Japan: Retrospective analysis of a nationwide survey

International Journal of Hematology

Volumn 87, Issue 1, 2008, Pages 48-55

  Hattori, Mamiko ^a   Terasawa, Teruhiko ^a   Tsushita, Keitaro ^a,b   Utsumi, Makoto ^a,c   Kawano, Fumio ^d   Saito, Hidehiko ^a   Shimoyama, Masanori ^a   Ohashi, Haruhiko ^a  

^a NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^b CHUKYO HOSPITAL   (Japan)

^c Takayama Kosei Hospital   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

Author keywords

Antithymocyte globulin (ATG); Aplastic anemia; Cyclosporine (CsA); Overall survival; Response rate

Indexed keywords

ANDROGEN; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTHRITIS; ARTICLE; BLEEDING; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG PULSE THERAPY; DRUG SAFETY; EDEMA; FEMALE; FEVER; HEALTH SURVEY; HOSPITAL; HUMAN; HYPERTENSION; IDIOPATHIC DISEASE; INFECTION; INFECTIOUS MONONUCLEOSIS; JAPAN; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; MORTALITY; QUESTIONNAIRE; SHOCK; STOMATITIS; THORAX PAIN; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VASCULITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAPAN; MALE; MIDDLE AGED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 41849133209     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-007-0016-9     Document Type: Article

References (15)

1. Camitta B, O'Reilly RJ, Sensenbrenner L, et al. Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia. Blood. 1983;62:883-8.
2. Champlin R, Ho W, Gale RP. Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. N Engl J Med. 1983;308:113-8.
3. Leonard EM, Raefsky E, Griffith P, Kimball J, Nienhuis AW, Young NS. Cyclosporine therapy of aplastic anemia, congenital and acquired red cell aplasia. Br J Haematol. 1989;72:278-84.
4. Hinterberger-Fischer M, Hocker P, Lechner K, Seewann H, Hinterberger W. Oral cyclosporin-A is effective treatment for untreated and also for previously immunosuppressed patients with severe bone marrow failure. Eur J Hematol. 1989;43:136-42.
5. Frickhofen N, Kaltwasser JP, Schrezenmeier H, et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or whithout cyclosporine. N Engl J Med. 1991;324:1297-304.
6. Marsh JCW, Ball SE, Darbyshire P, et al. Guidelines for the diagnosis and management of aquired aplastic anaemia. Br J Haematol. 2003;123:782-801.
7. Takaku F, Urabe A. Prospective study for the treatment of aplastic anemia. Annual Report of the Research Committee for Idiopathic Hematopoietic Disorders supported by the Ministry of Health and Welfare of Japan. 1984;127-33.
8. Frickhofen N, Heimpel H, Kaltwasser JP, et al. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood. 2003;101:1236-42.
9. Marsh JCW, Hws JM, Bryett KA, Al-Hashimi S, Fairhead SM, Gordon-Smith EC. Survival after antilymphocyte globulin therapy for aplastic anemia depends on disease severity. Blood. 1987;70:1046-52.
10. Kojima S, Hibi S, Kosaka Y, et al. Immunosuppressive therapy using antithymocyte globulin, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood. 2000;96:2049-54.
11. Rosenfeld SJ, Follmann D, Nunez O, Young NS. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA. 2003:289:1130-5.
12. Abkowitz JL, Powell JS, Nakamura JM, Kadin ME, Adamson JW. Pure red cell aplasia: response to therapy with antithymocyte globulin. Am J Hematol. 1986;23:363-71.
13. Paquette RL, Yoshimura R, Veiseh C, Kunkel L, Gajewski J, Rosen PJ. Clinical characteristics predict response to antithymocyte globulin in paroxysmal nocturnal haemoglobinuria. Br J Haematol. 1997;96:92-7.
14. Sadler M, Germing U, Kliche KO, et al. A prospective, randomized, phase II study of horse antithymcyte globulin vs. rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes. Leukemia. 2004;18:460-5.
15. Teramura M, Kimura K, Iwase S, et al. Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporin A with or without G-CSF in adults: a multicenter randomized study in Japan. Blood. 2007;110:1756-61.